Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kabamba Kabeya is active.

Publication


Featured researches published by Kabamba Kabeya.


AIDS | 1999

Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine

De Wit S; P. Cassano; Philippe Hermans; Kabamba Kabeya; Marcel Gérard; Elizabeth O'Doherty; Nathan Clumeck


Archive | 1998

Combined quadruple therapy with Ritonavir-Saquinavir+ nucleosides in patients who failed in triple therapy with Ritonavir, Saquinavir or Indinavir

P. Cassano; Philippe Hermans; Bernadette Sommereijns; Stéphane De Wit; Kabamba Kabeya; Elizabeth O'Doherty; Nathan Clumeck


Archive | 2002

Virological response to salvage therapy at 6 month in patients with B or non-B subtypes.

Philippe Hermans; Jean-Claude Schmit; Kabamba Kabeya; Elizabeth O'Doherty; Stéphane De Wit; Bernadette Sommereijns; Nathan Clumeck


Archive | 1999

Virological and immunological effects of Hydroxyurea salvage therapy in HIV infected patients

Philippe Hermans; Stéphane De Wit; Kabamba Kabeya; Bernadette Sommereijns; Nathan Clumeck


Archive | 1999

Cutaneous adverse events with abacavir and NNRTI combination: benefit of a delayed introduction of NNRTI

Kabamba Kabeya; Stéphane De Wit; Philippe Hermans; Elizabeth O'Doherty; Nathan Clumeck


AIDS | 1999

Ritonavir-saquinavir rescue therapy in HIV-positive patients failing with indinavir, ritonavir or saquinavir

De Wit S; P. Cassano; Philippe Hermans; Bernadette Sommereijns; Kabamba Kabeya; Elizabeth O'Doherty; Nathan Clumeck


Archive | 1998

141W94-AZT-3TC association:: a novel protease inhibitor added to long-standing AZT-3TC of combined with new reverse transcriptase inhibitors

P. Cassano; Stéphane De Wit; Philippe Hermans; Kabamba Kabeya; Marcel Gérard; Bernadette Sommereijns; Elizabeth O'Doherty; Nathan Clumeck


Archive | 1998

Genotypic and phenotypic sensitivity of viral isolates, in patients failing to AZT-3TC-141W94

P. Cassano; Philippe Hermans; Stéphane De Wit; Kabamba Kabeya; Elizabeth O'Doherty; Margaret Tisdale; Jane Yeo; Nathan Clumeck


Archive | 1998

Viral and immune response to Nelfinavir-Saquinavir or Ritonavir-Saquinavir, in HIV+ patients heavily pretreated with protease inhibitors

P. Cassano; Stéphane De Wit; Marcel Gérard; Philippe Hermans; Bernadette Sommereijns; Kabamba Kabeya; Frédérique De Cock; Nathan Clumeck


Archive | 1998

Picasso: a randomized comparative outcome trial of indinavir and ritonavir in protease inhibitors naiv HIV patients with CD4 below 100 cells/µl

Kabamba Kabeya; Stéphane De Wit; Bernadette Sommereijns; P. Cassano; Bernard Vandercam; B. Colebunders; Nathan Clumeck

Collaboration


Dive into the Kabamba Kabeya's collaboration.

Top Co-Authors

Avatar

Nathan Clumeck

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar

Philippe Hermans

Rega Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar

B. Colebunders

Institute of Tropical Medicine Antwerp

View shared research outputs
Top Co-Authors

Avatar

Bernard Vandercam

Cliniques Universitaires Saint-Luc

View shared research outputs
Top Co-Authors

Avatar

Jean-Claude Schmit

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge